Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Carl J Fichtenbaum"'
Autor:
Moises A Huaman, David Henson, Paola L Rondan, Eduardo Ticona, Gustavo Miranda, Richard J Kryscio, Raquel Mugruza, Ernesto Aranda, Cesar Ticona, Susan Abarca, Paula Heredia, Andres Aguirre, Timothy R Sterling, Beth A Garvy, Carl J Fichtenbaum
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202191 (2018)
BACKGROUND:We previously reported increased unstimulated blood levels of interferon-gamma in persons with latent tuberculosis infection (LTBI) in the United States, suggesting enhanced immune activation in LTBI. To investigate this further in a TB-en
Externí odkaz:
https://doaj.org/article/c03a161aceb24af5b40bc6c3c7f88c40
Autor:
Pietro Presicce, Kris Orsborn, Eileen King, Jesse Pratt, Carl J Fichtenbaum, Claire A Chougnet
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28118 (2011)
Regulatory T cells (Tregs) act by suppressing the activation and effector functions of innate and adaptive immune responses. HIV infection impacts Treg proportion and phenotype, although discrepant results have been reported depending on the patient
Externí odkaz:
https://doaj.org/article/9dc9ce5c18664fe090034d33f39dda56
Autor:
Márton Kolossváry, Chris deFilippi, Sara McCallum, Kathleen V. Fitch, Marissa R. Diggs, Evelynne S. Fulda, Heather J. Ribaudo, Carl J. Fichtenbaum, Judith A. Aberg, Carlos D. Malvestutto, Judith S. Currier, Jose L. Casado, Félix Gutiérrez, Irini Sereti, Pamela S. Douglas, Markella V. Zanni, Steven K. Grinspoon
Publikováno v:
EBioMedicine, Vol 90, Iss , Pp 104538- (2023)
Summary: Background: Mechanisms contributing to COVID-19 severity in people with HIV (PWH) are poorly understood. We evaluated temporal changes in plasma proteins following SARS-CoV-2 infection and identified pre-infection proteomic markers associate
Externí odkaz:
https://doaj.org/article/823472be514f4310a7c2fd39737de26a
Autor:
Samuel R. Schnittman, Wonyeong Jung, Kathleen V. Fitch, Markella V. Zanni, Sara McCallum, Jessica Shih-Lu Lee, Sally Shin, Brandon J. Davis, Evelynne S. Fulda, Marissa R. Diggs, Francoise Giguel, Romina Chinchay, Anandi N. Sheth, Carl J. Fichtenbaum, Carlos Malvestutto, Judith A. Aberg, Judith Currier, Douglas A. Lauffenburger, Pamela S. Douglas, Heather J. Ribaudo, Galit Alter, Steven K. Grinspoon
Publikováno v:
JCI Insight, Vol 8, Iss 5 (2023)
People with HIV (PWH) appear to be at higher risk for suboptimal pathogen responses and for worse COVID-19 outcomes, but the effects of host factors and COVID-19 on the humoral repertoire remain unclear. We assessed the antibody isotype/subclass and
Externí odkaz:
https://doaj.org/article/7c62f33fa7e2432ea3ea699651c5ca1d
Autor:
Laura Atehortua, Mirza Baig, Jamie Morris, Sarah Trentman, W. Sean Davidson, Carl J. Fichtenbaum, Claire A. Chougnet
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cardiovascular disease (CVD) is a leading cause of enhanced morbidity and mortality in persons with HIV (PWH) in the era of highly active antiretroviral therapy (AART). However, the underlying mechanisms are not fully understood. Regulatory T cells (
Externí odkaz:
https://doaj.org/article/4e030e8ea7424e92b4fe05dba8ee0479
Autor:
Carl J. Fichtenbaum, Laura B. Cho
Publikováno v:
Clinical Lipidology ISBN: 9780323882866
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4db6d1f4418e794c6bfe959413aa6a55
https://doi.org/10.1016/b978-0-323-88286-6.00040-6
https://doi.org/10.1016/b978-0-323-88286-6.00040-6
Autor:
Ali M. Agha, Lydia C. Alexander, Christie M. Ballantyne, Harold Bays, Deepak L. Bhatt, Roger S. Blumenthal, Michael B. Boffa, Rachel M. Bond, Julia M. Brandts, Eliot A. Brinton, Julie A. Brothers, Alberico L. Catapano, Dick C. Chan, Laura Chiavaroli, Laura Browning Cho, Leslie Cho, Danielle Cummings, Stephen R. Daniels, Matthew R. Deshotels, Erik Dove, David I. Feldman, Bengt Fellström, Keith C. Ferdinand, Carl J. Fichtenbaum, Angela Fitch, Daniel Gaudet, Henry N. Ginsberg, Ty J. Gluckman, Robert A. Hegele, Ron C. Hoogeveen, Aliza Hussain, Alan G. Jardine, David J.A. Jenkins, Peter H. Jones, Peter Jones, Sergey M. Kachur, Cyril W.C. Kendall, Joshua W. Knowles, Jon A. Kobashigawa, Marlys L. Koschinsky, Penny M. Kris-Etherton, Carl J. Lavie, Peter Libby, Santica M. Marcovina, Patrick B. Mark, Nicholas A. Marston, Seth Shay Martin, Erin D. Michos, Arash Mirrahimi, Samia Mora, Patrick M. Moriarty, Vijay Nambi, Adam J. Nelson, Stephen J. Nicholls, Steven E. Nissen, Børge Grønne Nordestgaard, Giuseppe Danilo Norata, Carl Orringer, Brian T. Palmisano, Darshna Patel, Rajan K. Patel, Vishnu Priya Pulipati, Frederick J. Raal, Daniel J. Rader, Kausik K. Ray, Chesney Richter, Paul M. Ridker, Marc S. Sabatine, Maya S. Safarova, Raul D. Santos, Joseph J. Saseen, Gregory G. Schwartz, Rachel J. Shustak, John L. Sievenpiper, Nickpreet Singh, Ann C. Skulas-Ray, Kristie Srichaikul, Neil J. Stone, Lale Tokgözoğlu, Anne Tybjærg-Hansen, Salim S. Virani, Karol Watson, Gerald F. Watts, Nanette K. Wenger, Julia M.W. Wong
Publikováno v:
Clinical Lipidology ISBN: 9780323882866
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e642184d4813f2294c46a5087cbf92b6
https://doi.org/10.1016/b978-0-323-88286-6.01002-5
https://doi.org/10.1016/b978-0-323-88286-6.01002-5
Autor:
Kathleen V. Fitch, Emma M. Kileel, Sara E. Looby, Markella V. Zanni, Laura R. Sanchez, Carl J. Fichtenbaum, Edgar T. Overton, Carlos Malvestutto, Judith A. Aberg, Karin L. Klingman, Beverly Alston-Smith, Judith Lavelle, Anne Rancourt, Sharlaa Badal-Faesen, Sandra Wagner Cardoso, Anchalee Avihingsanon, Sandesh Patil, Craig A. Sponseller, Kathleen Melbourne, Heather J. Ribaudo, Katharine Cooper-Arnold, Patrice Desvigne-Nickens, Udo Hoffmann, Pamela S. Douglas, Steven K. Grinspoon, on behalf of the REPRIEVE Investigators
Publikováno v:
HIV Research & Clinical Practice, Vol 21, Iss 1, Pp 11-23 (2020)
Background: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is a multicenter, randomized, placebo-controlled trial, designed to test whether a statin medication can prevent cardiovascular disease in people with HIV. REPRIEVE recentl
Externí odkaz:
https://doaj.org/article/c1bbcd7120594120b0af18d8c43b3e8f
Autor:
Kevin J. Haworth, Kelly C. Niederhausen, Eric P. Smith, Sakthivel Sadayappan, Yolanda Wess, Jack Rubinstein, Daniel P. Schauer, Manoocher Soleimani, Gregory W. Rouan, Carl J. Fichtenbaum
Publikováno v:
Academic Medicine.
Autor:
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, Tricia H Burdo, Kathleen V Fitch, Sara McCallum, Jacqueline M Flynn, Evelynne S Fulda, Marissa R Diggs, Jack T Stapleton, José L Casado, Jana Taron, Judith S Currier, Markella V Zanni, Carlos Malvestutto, Carl J Fichtenbaum, Judith A Aberg, Heather J Ribaudo, Michael T Lu, Pamela S Douglas, Steven K Grinspoon
Publikováno v:
Open forum infectious diseases, vol 10, iss 3
Background Inflammasome activation is increased in people with human immunodeficiency virus (PWH), but its relationship with coronary plaque is poorly understood in this setting. Methods In a large human immunodeficiency virus cardiovascular preventi